Factors that can make overall survival unreliable as a clinical trial outcome - Authors' reply.
Saved in:
| Title: | Factors that can make overall survival unreliable as a clinical trial outcome - Authors' reply. |
|---|---|
| Authors: | Gyawali B; Department of Oncology, Queen's University, Kingston, Ontario, Canada; Division of Cancer Care and Epidemiology, Sinclair Cancer Research Institute, Queen's University, Kingston, ON K7L 3N6, Canada. Electronic address: gyawali.bishal@queensu.ca., Stevens SX; Department of Oncology, Queen's University, Kingston, Ontario, Canada; Division of Cancer Care and Epidemiology, Sinclair Cancer Research Institute, Queen's University, Kingston, ON K7L 3N6, Canada., Teuwen LA; Department of Oncology, University Hospital of Antwerp, Edegem, Antwerp, Belgium. |
| Source: | The Lancet. Oncology [Lancet Oncol] 2026 Feb; Vol. 27 (2), pp. e67. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
